Rapid Therapeutic Science Laboratories
RTSL · OTC
About RTSL
- Employees
- 3
- Headquarters
- De Leon, Texas
- Listed
- Oct 31, 2013
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
RTSL key statistics
- Market cap
- 3.53K
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 252
- Volume
- 1
- Open price
- $0.0004
- High today
- $0.0004
- Low today
- $0.0004
- 52 Week high
- $0.007
- 52 Week low
- $0.0001
Rapid Therapeutic Science Laboratories (RTSL) at a glance
Rapid Therapeutic Science Laboratories (RTSL) last traded at $0.0004, with a market cap of 3.53K and a price-to-earnings ratio of 0.00.
Volume so far is 1 shares, below the average of 252 shares a day.
Over the past year Rapid Therapeutic Science Laboratories has ranged from $0.0001 to $0.007, and now sits 4% of the way up that range.
Similar companies
Companies in the same industry as Rapid Therapeutic Science Laboratories
Most active stocks
Highest trading volume today
- SHFSSHF Holdings$0.0899−4.36%
- WHLRWheeler Real Estate Investment Trust$0.3597+2.19%
- RBNERobin Energy$0.3978−23.65%
- SDSTStardust Power$0.02−23.66%
- WFFWF Holding$0.0929−3.83%
- RCTRedCloud Holdings$0.084+1.94%
- NWGLCL Workshop Group$0.1522+27.90%
- DKIDarkiris$0.0479−6.08%
- KORUDirexion Shares ETF Trust$11.34−4.87%
- AHTAshford Hospitality Trust$1.79−2.72%
- SOXLDirexion Shares ETF Trust$97.55−1.12%
- SPCXSpace Exploration Technologies$147.79−0.11%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.